Media contact: Stéphanie Bardon – communication@genethon.fr – 01.69.47.12.78
June 24, 2013
The European charity Myotubular Trust is supporting Généthon in developing gene therapy for myotubular myopathy
February 5, 2013
Genethon receives approval from the UK medicine regulatory agency to start a new clinical trial for an inherited immune deficiency: chronic granulomatous disease
November 8, 2012
Decree “advanced therapy medicinal products”: a new milestone for the AFM-Telethon and laboratory Genethon!
September 27, 2012
Genethon, member of the Biotherapies Institute for Rare Diseases
The Biotherapies Institute for Rare Diseases, a unique task force to accelerate therapeutic developments, includes 4 laboratories founded and supported by the AFM Telethon : the Institute of Myology, Genethon, I-Stem and Atlantic Gene Therapies (Nantes’ gene therapy research centre). (read more)
July 4, 2012
Alain Schwenck, an Expert on Pharmaceutical Prodcution, becomes Director of Genethon Bioprod
Alain Schwenck, 51, has joined Genethon as Director of Genethon Bioprod, the new site for the production of clinical grade-gene therapy medicines for the treatment of rare diseases, created by AFM-Telethon. (read more)
January 17, 2012
Fulvio Mavilio, the internationally acknowledged expert in gene therapy for rare diseases, is appointed as Genethon’s new Scientific Director
January 12, 2012
Gene therapy : Encouraging results in a Phase I clinical trial in limb-girdle muscular dystrophy type 2C
July 21, 2011
Genethon and Children’s Hospital Boston get FDA approval for a Wiskott Aldrich gene therapy trial
March 8, 2011
Genethon and Wake Forest University School of Medicine (North Carolina) announce their collaboration for a preclinical gene therapy trial
Evry (France), March 8th, 2011 – Genethon (the not-for-profit biotherapy lab funded by the French Muscular Dystrophy Association (Association Française contre les Myopathies, AFM) with donations from France’s annual Telethon) and Wake Forest University School of Medicine (Winston Salem, North Carolina, USA) today… (read more)
January 5, 2011
Partnership for a gene therapy Clinical trial signed between Genethon and Children’s Hospital Boston
December 14, 2010
bluebird bio and Généthon Announce Manufacturing Research Collaboration Centered on Lentiviral Vectors for Gene Therapy
February 24, 2010
Généthon initiates a new clinical trial for a severe immune deficiency (Wiskott-Aldrich syndrome)
February 23, 2010
